Over the past few years, substantial progress has been made in the field of stem cell regeneration of the intervertebral disc. Autogenic mesenchymal stem cells in animal models can arrest intervertebral disc degeneration or even partially regenerate it and the effect is suggested to be dependent on the severity of degeneration. Mesenchymal stem cells (MSCs) are able to escape alloantigen recognition which is an advantage for allogenic transplantation. A number of injectable scaffolds have been described and various methods to pre-modulate MSCs' activity have been tested. In future, work will need to address the use of mesenchymal stem cells in large animal models and the fate of the implanted mesenchymal stem cells, particularly in the long term, in animals. This review examines the state-of-the-art in the field of stem cell regeneration of the intervertebral disc, and critically discusses, with scientific support, the issues involved, before stem cells could be used in human subjects. [79,81]. In the development of organism, the single totipotent cell after fertilization divides and specializes into pluripotent cells, such as embryonic stem cells that are necessary for fetal development. The pluripotent cells then further specialize into multipotent cells that commit into lineages with tissue-specific functions. Cells have been successfully identified in or isolated from embryonic [70], fetal [34, 73], or adult tissues [45] and demonstrated to have stem cell-like properties in vitro and in vivo. The maintenance, survival and activity of these stem cells is suggested to be dependent on the special micro-environmental niche [45], such that uncommitted pluripotent stem cells can be induced to differentiate to form a particular cell type by the nature of the environment. Additionally, the pluripotency of stem cells depends on the source, the method of isolation, and conditions of ex-vivo cell processing.